Advances in Nano-Functional Materials in Targeted Thrombolytic Drug Delivery

Author:

Ren Tengfei12,Mi Yuexi2,Wei Jingjing2,Han Xiangyuan2,Zhang Xingxiu2,Zhu Qian2,Yue Tong1,Gao Wenhao1,Niu Xudong1,Han Cuiyan2,Wei Bing3

Affiliation:

1. School of Basic Medical Sciences, Qiqihar Medical University, Qiqihar 161006, China

2. School of Pharmacy, Qiqihar Medical University, Qiqihar 161006, China

3. School of Materials Science and Engineering, Heilongjiang University of Science and Technology, Harbin 150022, China

Abstract

Thrombotic disease has been listed as the third most fatal vascular disease in the world. After decades of development, clinical thrombolytic drugs still cannot avoid the occurrence of adverse reactions such as bleeding. A number of studies have shown that the application of various nano-functional materials in thrombus-targeted drug delivery, combined with external stimuli, such as magnetic, near-infrared light, ultrasound, etc., enrich the drugs in the thrombus site and use the properties of nano-functional materials for collaborative thrombolysis, which can effectively reduce adverse reactions such as bleeding and improve thrombolysis efficiency. In this paper, the research progress of organic nanomaterials, inorganic nanomaterials, and biomimetic nanomaterials for drug delivery is briefly reviewed.

Funder

National Natural Science foundation of China

University Student Innovation and Entrepreneurship Training Program in Heilongjiang Province

Publisher

MDPI AG

Reference141 articles.

1. Global Burden of Thrombosis: Epidemiologic Aspects;Wendelboe;Circ. Res.,2016

2. Current and future burden of venous thrombosis: Not simply predictable;Scheres;Res. Pract. Thromb. Haemost.,2018

3. An Overview of the “China Cardiovascular Health and Disease Report 2022”;Hu;Chin. J. Cardiovasc. Rev.,2023

4. Heart Disease and Stroke Statistics-2023 Update: A Report from the American Heart Association;Tsao;Circulation,2023

5. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review;Bikdeli;J. Am. Coll. Cardiol.,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3